What is ANI Pharmaceuticals's current debt?

ANI Pharmaceuticals (ANIP) reported current debt of $19.3M in Q1 2026.

How has ANI Pharmaceuticals's current debt changed year-over-year?

ANI Pharmaceuticals's current debt increased by 72.4% year-over-year, from $11.19M to $19.3M.

What is the long-term trend for ANI Pharmaceuticals's current debt?

Over 5 years (2020 to 2025), ANI Pharmaceuticals's current debt has grown at a 5.5% compound annual growth rate (CAGR), from $13.24M to $17.27M.

What does current debt mean?

The portion of long-term debt maturing within the next 12 months, requiring refinancing or repayment from operating cash flows.

ANI Pharmaceuticals ANIP Current Debt

Current Debt at other companies

Amneal Pharmaceuticals, Inc.AMRX

$6.2M-80.5%

ViatrisVTRS

$1.93B+22,619%

Aurinia PharmaceuticalsAUPH

$16.52M+13.9%

AmgenAMGN

$5.44B+61.4%

OrganonOGN

$16M-20.0%

IncyteINCY

$4.41M-1.5%

Other financials

Income statement

See full

Revenue$237.5M+20.5%

Gross profit$143.9M+16.0%

Operating income$38.9M+48.5%

Net income$29.5M+88.1%

EPS (diluted)$1.28+85.5%

Balance sheet

See full

Cash & equivalents$311.2M+108%

Total debt$305.3M-3.5%

Total equity$562.3M+34.3%

Total assets$1.4B+10.0%

Cash flow

See full

Operating cash flow$58.4M+66.8%

CapEx$6.1M+146%

Free cash flow$52.3M+60.8%

Valuation

See full

Market cap$1.89B+18.3%

Enterprise value$1.88B+5.8%

P/E20.5×—

P/S2×-0.3×

Profitability

See full

Gross margin60.8%+1.5pp

Operating margin13.4%—

Net margin10%+8.1pp

FCF margin20.7%+10.8pp

Returns & leverage

See full

Return on equity18.8%+15.6pp

Debt / equity0.5×-0.2×

Current ratio3.1×+0.5×

Where this comes from

Reported directly by ANI Pharmaceuticals in its filing.

Tagged under the XBRL concept us-gaap:LongTermDebtCurrent.

The official record: ANI Pharmaceuticals’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →

Ask your AI about ANI Pharmaceuticals's current debt.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is ANI Pharmaceuticals's current debt?: ANI Pharmaceuticals (ANIP) reported current debt of $19.3M in Q1 2026.
How has ANI Pharmaceuticals's current debt changed year-over-year?: ANI Pharmaceuticals's current debt increased by 72.4% year-over-year, from $11.19M to $19.3M.
What is the long-term trend for ANI Pharmaceuticals's current debt?: Over 5 years (2020 to 2025), ANI Pharmaceuticals's current debt has grown at a 5.5% compound annual growth rate (CAGR), from $13.24M to $17.27M.
What does current debt mean?: The portion of long-term debt maturing within the next 12 months, requiring refinancing or repayment from operating cash flows.